Register Now: Image-Based Risk: The Next Frontier in Breast Cancer Screening
|Articles|April 2, 1997

Fonar pursues legal battle with MR Plus

Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S.

Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S. District Court for the southern district of New York also ordered a new trial, according to Fonar.

In December, a federal jury had awarded MR Plus $2.3 million, but the verdict was later overturned by the appeals court in January, which also reinstated Fonar's copyright-infringement and unfair-competition claims (SCAN 3/5/97).

Related to this article

Emerging Research Insights and New Advances in Neuroradiology
Catch up on key neuroradiology news and research from the past month, including recently published studies involving white matter hyperintensity findings on brain MRI, MRI-enhanced amyloid PET and the newly FDA-approved PET agent floretyrosine F18 for glioma imaging.
Current Perspectives on Integrating AI into Radiology
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.